1P-ETH-LAD
1-Propionyl-6-ethyl-6-nor-lysergic acid diethyamide
 
(8β)-N,N,6-Triethyl-1-propanoyl-9,10-didehydroergoline-8-carboxamide
 5917 ·  C24H31N3O2 ·  393.522
 InChI=1S/C24H31N3O2/c1-5-22(28)27-15-16-13-21-19(18-10-9-11-20(27)23(16)18)12-17(14-26(21)8-4)24(29)25(6-2)7-3/h9-12,15,17,21H,5-8,13-14H2,1-4H3/t17-,21-/m1/s1
 MLOFCBXSOAYCIF-DYESRHJHSA-N This stereoisomer Any stereoisomer
 CCN1C[C@@H](C=C2[C@H]1Cc1cn(c3c1c2ccc3)C(=O)CC)C(=O)N(CC)CC

Brandt, SD; Kavanagh, PV; Westphal, F; Elliott, SP; Wallach, J; Stratford, A; Nichols, DE; Halberstadt, AL. Return of the lysergamides. Part III: Analytical characterization of N6-ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD). Drug Test. Analysis, 1 Oct 2017, 9 (10), 1641-1649. 1.2 MB. https://doi.org/10.1002/dta.2196

Brandt, SD; Kavanagh, PV; Twamley, B; Westphal, F; Elliott, SP; Wallach, J; Stratford, A; Klein, LM; McCorvy, JD; Nichols, DE; Halberstadt, AL. Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775). Drug Test. Analysis, 1 Feb 2018, 10 (2), 310-322. 1.2 MB. https://doi.org/10.1002/dta.2222

EMCDDA. New drugs in Europe, 2017, European Monitoring Centre for Drugs and Drug Addiction, 1 Aug 2017. 672 kB. #31

2AD-ATHPINACA
ATHPINACA
1B-LSD
13 November 2018 · Creative Commons BY-NC-SA ·